TipRanks
Radiopharm Theranostics Limited Sponsored ADR (RADX)
NASDAQ:RADX
US Market
RADX
Radiopharm Theranostics Limited Sponsored ADR
RESEARCH TOOLSreports
Want to see RADX full AI Analyst Report?

Radiopharm Theranostics Limited Sponsored ADR (RADX) Income Statement

64 Followers

Radiopharm Theranostics Limited Sponsored ADR Income Statement

Last quarter (Q4 2025), Radiopharm Theranostics Limited Sponsored ADR's total revenue was AU$1.40M, an increase of 3.07% from previous quarter. In Q4, Radiopharm Theranostics Limited Sponsored ADR's net income was AU$-28.58M. See Radiopharm Theranostics Limited Sponsored ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 25Jun 24Jun 23Jun 22Jun 22
Total Revenue
AU$ 2.71MAU$ 3.63MAU$ 299.23KAU$ 8.83KAU$ 292.36K
Gross Profit
AU$ -2.10MAU$ 39.28KAU$ 299.23KAU$ 8.83KAU$ 292.36K
Operating Expenses
AU$ 64.73MAU$ 38.21MAU$ 36.92MAU$ 19.93MAU$ 34.80M
Depreciation and Amortization
AU$ 0.00AU$ 7.33KAU$ 3.13MAU$ 2.98MAU$ 3.30M
EBITDA
AU$ -66.84MAU$ -38.17MAU$ -44.08MAU$ -17.96MAU$ -31.19M
Operating Income
AU$ -66.84MAU$ -38.17MAU$ -36.62MAU$ -19.92MAU$ -34.51M
Other Income/Expenses
AU$ 11.18MAU$ -65.30KAU$ -11.23MAU$ -10.38MAU$ -65.10K
Pretax Income
AU$ -55.65MAU$ -38.24MAU$ -47.85MAU$ -30.29MAU$ -34.57M
Net Income
AU$ -53.94MAU$ -38.34MAU$ -47.95MAU$ -30.34MAU$ -34.61M
Per Share Metrics
Basic EPS
AU$ -4.56AU$ -5.28AU$ -36.00AU$ -29.76AU$ -33.00
Diluted EPS
AU$ -4.56AU$ -5.28AU$ -36.00AU$ -29.76AU$ -33.00
Weighted Average Shares Outstanding
 11.81M 6.94M 1.29M 1.02M 1.02M
Weighted Average Shares Outstanding (Diluted)
 11.81M 6.94M 1.29M 1.02M 1.02M
Currency in AUD

Radiopharm Theranostics Limited Sponsored ADR Earnings and Revenue History